<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pettit N</submitter><funding>NICHD NIH HHS</funding><funding>US National Institutes of Child Health &amp;amp; Human Development</funding><funding>US National Institutes of Genetic Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>190-5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3441828</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>402(2)</volume><pubmed_abstract>Escherichia coli O127:K63(B8) possesses high human blood group H (O) activity due to its O-antigen repeating unit structure. In this work, the wbiQ gene from E. coli O127:K63(B8) was expressed in E. coli BL21 (DE3) and purified as a fusion protein containing an N-terminal GST affinity tag. Using the GST-WbiQ fusion protein, the wbiQ gene was identified to encode an α1,2-fucosyltransferase using a radioactivity based assay, thin-layer chromatography assay, as well confirming product formation by using mass spectrometry and NMR spectroscopy. The fused enzyme (GST-WbiQ) has an optimal pH range from 6.5 to 7.5 and does not require the presence of a divalent metal to be enzymatically active. WbiQ displays strict substrate specificity, displaying activity only towards acceptors that contain Gal-</pubmed_abstract><journal>Biochemical and biophysical research communications</journal><pubmed_title>Characterization of WbiQ: An α1,2-fucosyltransferase from Escherichia coli O127:K63(B8), and synthesis of H-type 3 blood group antigen.</pubmed_title><pmcid>PMC3441828</pmcid><funding_grant_id>R01 HD061935</funding_grant_id><funding_grant_id>R01 GM085267</funding_grant_id><pubmed_authors>Wang PG</pubmed_authors><pubmed_authors>Pettit N</pubmed_authors><pubmed_authors>Mei Z</pubmed_authors><pubmed_authors>Han W</pubmed_authors><pubmed_authors>Zhao G</pubmed_authors><pubmed_authors>Styslinger T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterization of WbiQ: An α1,2-fucosyltransferase from Escherichia coli O127:K63(B8), and synthesis of H-type 3 blood group antigen.</name><description>Escherichia coli O127:K63(B8) possesses high human blood group H (O) activity due to its O-antigen repeating unit structure. In this work, the wbiQ gene from E. coli O127:K63(B8) was expressed in E. coli BL21 (DE3) and purified as a fusion protein containing an N-terminal GST affinity tag. Using the GST-WbiQ fusion protein, the wbiQ gene was identified to encode an α1,2-fucosyltransferase using a radioactivity based assay, thin-layer chromatography assay, as well confirming product formation by using mass spectrometry and NMR spectroscopy. The fused enzyme (GST-WbiQ) has an optimal pH range from 6.5 to 7.5 and does not require the presence of a divalent metal to be enzymatically active. WbiQ displays strict substrate specificity, displaying activity only towards acceptors that contain Gal-</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Nov</publication><modification>2026-05-04T20:46:06.613Z</modification><creation>2019-03-27T00:57:56Z</creation></dates><accession>S-EPMC3441828</accession><cross_references><pubmed>20801103</pubmed><doi>10.1016/j.bbrc.2010.08.087</doi></cross_references></HashMap>